67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 221 / Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02134899 (ClinicalTrials.gov)	October 14, 2014	28/4/2014	The Efficacy of Everolimusin Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transp ...	An Open-labelled Multicenter Randomized Study on the Efficacy of Everolimusin Reducing Total Native ...	Autosomal Dominant Polycystic Kidney Disease	Drug: Everolimus;Drug: Calcineurin inhibitors maintenance	Assistance Publique - Hôpitaux de Paris	Novartis	Completed	18 Years	75 Years	All	3	Phase 3	France
2	NCT01009957 (ClinicalTrials.gov)	June 2008	6/11/2009	Everolimus on CKD Progression in ADPKD Patients	Everolimus on CKD (Chronic Kidney Disease) Progression in ADPKD Patients	Polycystic Kidney Diseases	Drug: Everolimus	A. Manzoni Hospital	NULL	Terminated	18 Years	N/A	Both	71	Phase 2/Phase 3	Italy
3	EUCTR2006-001485-16-FR (EUCTR)	20/08/2007	23/07/2007	A multicenter, randomized, placebo-controlled, double-blind study on the efficacy, safety and tolera ...	A multicenter, randomized, placebo-controlled, double-blind study on the efficacy, safety and tolera ...	polycystic kidney disease MedDRA version: 8.1;Level: LLT;Classification code 10011771;Term: Cystic k ...	Product Name: Certican Product Code: RAD001 INN or Proposed INN: Everolimus	Novartis Pharma GmbH	NULL	Not Recruiting			Female: yes Male: yes	300		France;Austria;Germany
4	EUCTR2006-001485-16-AT (EUCTR)	15/12/2006	16/11/2006	A multicenter, randomized, placebo-controlled, double-blind study on the efficacy, safety and tolera ...	A multicenter, randomized, placebo-controlled, double-blind study on the efficacy, safety and tolera ...	polycystic kidney disease MedDRA version: 8.1;Level: LLT;Classification code 10011771;Term: Cystic k ...	Product Name: Certican Tabletten Product Code: RAD001 INN or Proposed INN: Everolimus	Novartis Pharma GmbH	NULL	Not Recruiting			Female: yes Male: yes	300		France;Austria;Germany
5	NCT00414440 (ClinicalTrials.gov)	December 2006	20/12/2006	Efficacy, Safety and Tolerability of Everolimusin Preventing End-stage Renal Disease in Patients Wit ...	A Multicenter, Randomized, Placebo-controlled, Double-blind Study on the Efficacy, Safety and Tolera ...	Autosomal Dominant Polycystic Kidney Disease	Drug: Placebo;Drug: Everolimus	Novartis Pharmaceuticals	NULL	Completed	18 Years	50 Years	All	431	Phase 4	Austria;France;Germany
6	EUCTR2006-001485-16-DE (EUCTR)	25/10/2006	19/01/2007	A multicenter, randomized, placebo-controlled, double-blind study on the efficacy, safety and tolera ...	A multicenter, randomized, placebo-controlled, double-blind study on the efficacy, safety and tolera ...	polycystic kidney disease MedDRA version: 8.1;Level: LLT;Classification code 10011771;Term: Cystic k ...	Product Name: Certican Tabletten Product Code: RAD001 INN or Proposed INN: Everolimus	Novartis Pharma GmbH	NULL	Not Recruiting			Female: yes Male: yes	300		France;Austria;Germany

First Previous1Next Last